|Year : 2022 | Volume
| Issue : 1 | Page : 8-18
Comparative phytochemical and HPTLC analysis of Nisha (Curcuma longa Linn.) chunra (powder), Amalaki (Phyllanthus emblica Linn.) churna (powder), and Nisha Amalaki churna (powder)
Pravin Jawanjal1, Prashant Bedarkar1, BJ Patgiri1, VJ Shukla2
1 Department of RS&BK, ITRA, Jamnagar, Gujarat, India
2 Pharmaceutical Lab, ITRA, GAU, Jamnagar, Gujarat, India
|Date of Submission||21-Dec-2021|
|Date of Acceptance||09-Mar-2022|
|Date of Web Publication||12-Aug-2022|
Mr. Pravin Jawanjal
Department of Rasashastra and Bhaishajya Kalpana, ITRA, Gujarat Ayurved University, Jamnagar, Gujarat
Source of Support: None, Conflict of Interest: None
Aim: The aim of this study was to evaluate phytochemical constituent and high-performance thin-layer chromatography (HPTLC) analysis of Nisha churna, Amalaki churna, and Nishamalaki churna.Introduction: Nisha churna, Amalaki churna, and Nishamalaki churna are important formulations, which are used in many disorders and a constituent of numerous Ayurvedic formulations. Materials and Methods: This study was conducted on Nisha churna, Amalaki churna, and Nishamalaki churna (authenticated), as per standard method. Results: Identification of steroid, alkaloids, and amino acids were confirmed by authenticated phytochemical standard parameter. Conclusion: Physiochemical analysis including HPTLC of Nisha churna, Amalaki churna, and Nishamalaki churna will help in further standardization.
Keywords: Amalaki churna, HPTLC, Nisha churna, Nishamalaki churna
|How to cite this article:|
Jawanjal P, Bedarkar P, Patgiri B J, Shukla V J. Comparative phytochemical and HPTLC analysis of Nisha (Curcuma longa Linn.) chunra (powder), Amalaki (Phyllanthus emblica Linn.) churna (powder), and Nisha Amalaki churna (powder). J Ayurveda Homeopath Allied Health Sci 2022;1:8-18
|How to cite this URL:|
Jawanjal P, Bedarkar P, Patgiri B J, Shukla V J. Comparative phytochemical and HPTLC analysis of Nisha (Curcuma longa Linn.) chunra (powder), Amalaki (Phyllanthus emblica Linn.) churna (powder), and Nisha Amalaki churna (powder). J Ayurveda Homeopath Allied Health Sci [serial online] 2022 [cited 2022 Sep 26];1:8-18. Available from: http://www.dpujahas.org/text.asp?2022/1/1/8/353700
| Introduction|| |
Nisha Amalaki Churna, Kalpa (formulation) with Nisha (Curcuma longa Linn.) Churna (powder) and Amlaki (Phyllanthus emblica Linn.) Churna (powder) are described in Ayurvedic texts and Nighantus.Amalaki has been mentioned one of the best rejuvenates in Ayurveda. It contents include, phosphorous, iron, calcium, thiamine, carotene, riboflavin, and niacin. Pharmacological activities of Amalaki,,,,,, have been evaluated as beneficial in the management of diabetes. Emblica officinalis is proposed to possess antidiabetic actions as antihyperglycemic, insulin-mimetic action, alpha amylase and alphaglucosidase inhibition,E. officinalis beneficial in the retardation of diabetic nephropathy.,,
The other ingredient Haridra has antibacterial activity and healing qualities. Pharmacological activities of Nisha, have been evaluated as beneficial in the management of diabetes. Curcuma longa is proposed to possess antidiabetic actions as alpha amylase, antidiabetic, and alphaglucosidase inhibition., The additive effect in between Nisha and Amalaki existed as antihyperglycemic effect.Clinical studies of Haridra Churna 3 g BD with Saptavimshatika Guggulu 1 g BD for the 90 days reported that statistically insignificant reduction in fasting and PPBS but significant reduction in HbA1C. Formulation Nishamalak Churna i may be considered as a composition formulation or drug combination or mode of administration of drug or fixed drug combination. There are many references in ancient Ayurvedic scripts for the use and efficacy of Nisha, Amalaki, and various combinations of Nisha and Amalaki in the treatment of Prameha. As per literature, both the drugs are mentioned to have many benefits in healthy and diseased state and are mentioned as Rasayana (rejuvenation).
Nisha Amalaki Churna 1 gm (two times a day) for 6 weeks in 25 patients in each group reported that statistically less significant results in FBS and PPBS parameters.
Researches had proven its beneficial effects on the prevention of cardiovascular diseases, cataracts, cerebrovascular diseases, peripheral vascular diseases, retarding of diabetic nephropathy, and retinopathy with variable results. Nisha AmalakiChurna, various Kalpa of Amalaki, and Haridra, are mentioned in the texts of Ayurveda. Comparative physicochemical parameters and high-performance thin-layer chromatography (HPTLC) profile of Nisha churna, Amalaki churna, and Nishamalaki churna are not available in published and authentic literature. The aim of this study was to compare HPTLC fingerprint of Nisha churna, Amalaki churna, and Nishamalaki Churna along with present phytochemical constituent, physicochemical profile.
| Materials and Methods|| |
Raw materials were authenticated from the pharmacognosy department. The Churna (powders) were prepared from the Nisha and Amalaki. These powders were sieved (#100) and mixed together in mortar equal proportion. The blended Churna was labeled as Nishamalaki churna and subjected to further analysis.
Sample were Nisha Churna, Amalaki Churna, and Nisha amalaki Churna
Site of study
Authentication of sample drugs were done in the pharmacognosy laboratory of ITRA.
Authentication of Nisha churna, Amalaki churna, and Nishamalaki churna were done based on organoleptic characters, morphological features, transverse section, and powder microscopy as mentioned in Ayurvedic Pharmacopoeia of India (API) and textbook of pharmacognosy.,, The phytochemical constituent, physicochemical study along with HPTLC fingerprint of Nisha churna, Amalaki churna, and Nishamalaki churna was conducted in the pharmaceutical laboratory of ITRA.
Observations were carried out with help of sensory organs.
The Churna were exposed to parameters, that is, loss on drying pH, total ash value, water-soluble extractive value, acid-insoluble ash value, and alcohol soluble extractive value. For qualitative analysis, the powders were dissolved in alcohol extract.
Methanol extract of test drugs samples was used for HPTLC. The test drugs samples were spotted with pre-coated silica gel GL60254 aluminum plates as 10 mm bands by the means of a CAMAG Linomate V samples applicator fixed with 100 μL the Hamilton syringe. Toluene (9 mL) and ethyl acetate (1 mL) were taken for test drugs as a mobile phase. After development, densitometry scanning was carried out with the CAMAG thin-layer chromatography scanner III in the reflectance absorbance mode at 366 nm and 254 nm under the control of Win CATS software (V1.2.1. CAMAG), (Stahl E., 1969), (Reich E, Schibii A., 2007).
| Results and Discussion|| |
Physicochemical parameters and qualitative phytochemical parameters Organoleptic evaluation
The powder of Amalak was dark brown with sour odor, sour astringent in Rasa (taste), and course fine in Sparsha (touch)and was mentioned in [Table 1]. Powder of Nisha was orangish-yellow in color, aromatic in odor, astringent in taste, and fine in touch [Table 2]. Powder of Nishamalaki was dull yellowish-brown, slightly aromatic, sour astringent, and fine in organoleptic evaluation [Table 3].
Diagnostic characters of Amalaki powder show that crystals of silica, brown content, fragmented simple fiber, mesocarp cell, group of sclerides, epicarp cell, after staining lignified group of scleroid, fragment of spiral vessel, fragment of annular vessels and parenchyma cells [Figure 1]. Diagnostic characters of Nisha powder show that parenchyma cell, group of simple starch, cork in surface view, scalariform vessel, simple fiber and after staining Cork in Trans giant View [Figure 2]. Diagnostic characters of Nishamalaki powder show that fragment of silica deposition of Amalaki, scalariform vessel of Haridra, starch grain of Haridra, parenchyma cell of Haridra, mesocarp cell of Amalaki, simple fiber of Haridra, scleroid of Amalaki, oleoresin content of Haridra, cork cells in tangent ant view of Haridra, and epicarp cell of Amalaki [Figure 3].
|Figure 1: Pharmacognosy of Amalaki: (A) Silica deposition. (B) Brown content. (C) Fragmented simple fiber. (D) Scleroid. (E) Mesocarp cell. (F) Group of scleroid. (G) Epicarp cells. After staining: (H) Lignified group of scleroid. (I) Fragment of spiral vessel|
Click here to view
|Figure 2: Pharmacognosy of Nisha churna: (A) Parenchyma cell. (B) Group of simple starch. (C) Cork in surface view. (D) Scalariform vessel. (E) Simple fiber. After staining: (F) Cork in trans giant view. (G) Cork in trans giant view. (H) Cork in trans giant view|
Click here to view
|Figure 3: Pharmacognosy of Nisamalaki Churna: (A) Fragment of scalariform vessel of Haridra. (B) Silica deposition of Amalaki. (C) Starch grain of Haridra. (D) Parenchyma cell of Haridra. (E) Mesocarp cell of Amalaki. (F) Simple fiber of Haridra. (G) Scleroid of Amalaki. (H) Oleoresin content of Haridra. (I) Cork cells in tangent ant view of Haridra. (J) Epicarp cell of Amalaki. (K) Epicarp cell of Amalaki|
Click here to view
The physicochemical parameters of Amalaki Churna reveal that foreign matter was not present and other parameters were loss on drying 13.09%, ash value 6.20%, acid-insoluble ash 31.76%, water-soluble extractive 32.48, alcohol-soluble extractive 22.36, and pH (5% suspension in water) 3.25 [Table 4]. Nisha churna show that was not present and other values are loss on drying 13.14%, ash value 2.6%, acid-insoluble ash 61.56%, water-soluble extractive 32.48%, alcohol-soluble extractive7.4, and pH (5% suspension in water) 5.72 [Table 4]. Nisha amalaki shows that foreign matter was absent and other values were loss on drying 13.09%, ash value 3.75%, acid-insoluble ash 61.56%, water-soluble extractive 31.50%, alcohol-soluble extractive17.36%, and pH (5% suspension in water) 4.74.
Nisha Churna (methanol extract) revealed that presence of steroid, alkaloids, carbohydrates. Qualitative analysis of methanol extracts of Amalaki methanol revealed that the presence of alkaloids, tannins, phenols, carbohydrates. steroid. Qualitative analysis of methanol extracts of Amalaki revealed the presence of alkaloids, tannins, phenols, carbohydrates, steroid, flavanoids, and reducing sugar whereas methanol extracts of Nishamalaki revealed the presence of carbohydrates, steroids, tannins, phenols, alkaloids, and reducing sugar [Table 5].
|Table 5: Qualitative phytochemical parameters of Nisha, Amalaki, and Nisha Amalaki|
Click here to view
HPTLC profile of Amalaki churna (methanol extract) reveals that 6 peaks and 4 peaks, UV spectrum of 254 nm and 366 nm, respectively. HPTLC profile of Nisha churna (methanol extract) shows that 5 peaks in 254 nm and 5 peaks in 366 nm of UV spectrum, respectively. The Rf values are shown in [Table 4] and the photographs and peak display are presented in [Figure 4][Figure 5][Figure 6][Figure 7]. The Rf values obtained at 254 nm and 366 nm is 0.02 and 0.02, respectively [Table 6]. HPTLC profile of Nisha Amalaki Churna (methanol extract) reveals that 6 peaks and 5 peaks in UV visible range of 254 nm and 366 nm, respectively. In spectral comparison Nisha Churna, Amalaki Churna shows that Rf value 0.89 whereas Nisha Churna, Amalaki Churna, Nisha-Amalaki Churna Rf 0.93. In previous study of Nisha-Amalaki Churna reported that Rf values were 0.29, 0.37, 0.59, 0.63, 0.70, 0.95 in the solvent system of toluene:ethyl acetate:formic acid (10:7:1). In this study, toluene and ethyl acetate ((9 mL and 1 mL) were used for test drugs as a mobile phase. The HPTLC profile of this study reveals that most common Rf value is 0.93 in Nisha Churna, Amalaki Churna, and Nisha-Amalaki Churna.
|Figure 4: HPTLC of Amalaki Churna: (A) HPTLC of Amalaki Churna 254 nm. (B) HPTLC of Amalaki Churna 366 nm. (C) Peak of HPTLC of Amalaki Churna 254 nm. (D) Peak of HPTLC of Amalaki Churna 366 nm. (E) Peak of HPTLC of Amalaki Churna IN 3D 254 nm. (F) Peak of HPTLC of Amalaki Churna IN 3D 366 nm. (G) HPTLC of Amalaki Churna. (H) Amalaki Churna|
Click here to view
|Figure 5: HPTLC of Nisha Churna: (A) HPTLC of Nisha Churna 254 nm. (B) HPTLC of Nisha Churna 366 nm. (C) Peak of HPTLC of Nisha Churna 254 nm. (D) Peak of HPTLC of Nisha Churna 366 nm. (E) Peak of HPTLC of Nisha Churna in 3D 254 nm. (F) Peak of HPTLC of Nisha Churna in 3D 366 nm. (G) HPTLC of Nisha Churna. (H) Nisha Churna|
Click here to view
|Figure 6: HPTLC of Nisha Amalaki Churna: (A) HPTLC of Nisha Amalaki Churna in 254 nm. (B) HPTLC of Nisha Amalaki Churna in 366 nm. (C) Peak of HPTLC of Nisha Amalaki Churna in 254 nm. (D) Peak of HPTLC of Nisha Amalaki Churna in 366 nm. (E) Peak of HPTLC of Nisha Amalaki Churna in 3D 254 nm. (F) Peak of HPTLC of Nisha Amalaki Churna in 3D 366 nm. (G) HPTLC of Nisha Amalaki Churna. (H) Nisha Amalaki Churna|
Click here to view
|Figure 7: Comparative spectrum of HPTLC of Amalaki Churna, Nisha Churna, and Nishamalaki Churna: (A) Nisha Churna and Amalaki Churna (Rf 0.89) and (B) Nisha Churna, Amalaki Churna, and Nishamalaki Churna (Rf 0.93)|
Click here to view
|Table 6: HPTLC analysis: Physicochemical parameters and Rf values obtained at ultraviolet [Figure 1]–[Figure 4]|
Click here to view
| Conclusion|| |
Nisha churna, Amalaki churna, and Nishamalaki churna are important formulations, which are widely used in various ailments and as constituent of numerous Ayurvedic formulations. Physiochemical analysis including HPTLC of Nisha Churna, Amalaki Churna, and Nisha-Amalaki Churna can be used in upcoming studies and quantify the chemical constituents applied in different therapeutic aspects.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Shengule S, Kumbhare K, Patil D, Mishra S, Apte K, Patwardhan B Herb-drug interaction of Nisha Amalaki
and curcuminoids with metformin in normal and diabetic condition: A disease system approach. Biomed Pharmacother 2018;101:591-8.
Kaur J, Kaur D, Singh H, Khan MU. Emblica officinalis: A meritocratic drug for treating various disorders. Indo Am J Pharm Res 2013:3:4477-96.
Bhandari Prasant R, Kamdod M Emblica officinalis (Amla): A review of potential therapeutic applications. Int J Green Pharm 2012;6:257-69.
Baliga MS, Dsouza JJ Amla (Emblica officinalis
Gaertn): A wonder berry in the treatment and prevention of cancer. Eur J Cancer Prev 2011;20:225-39.
Khosla S, Sharma S A short description on pharmacogenetic properties of Emblica officinalis. Spatula DD – Peer Reviewed J Complement Med Drug Discov 2012;2:187-93.
Kasabri V, Flatt PR, Abdel-Wahab Y Emblica officinalis stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro. Eur J Med Plants 2014;4:753-70.
Dasaroju S, Gottumukkala KM Current trends in the research of Emblica officinalis (Amla
): A pharmacological perspective. Int J Pharm Sci Rev Res 2014;24:150-9.
Khan KH Roles of Emblica officinalis
in medicine: A review. Bot Res Int 2009;2:218-28.
Patel SS, Goyal RK, Shah RS, Tirgar PR, Jadav PD Experimental study on effect of hydroalcoholic extract of Emblica officinalis
fruits on glucose homeostasis and metabolic parameters. Ayu 2013;34:440-4.
Poongunran J α-Glucosidase and α-Amylase inhibitory activities of nine Sri Lankan antidiabetic plants. Br J Pharm Res 2015;7:365-74.
Potekar Ratnakar M, Patil S, Desai SD, Kanthe P Effect of ethanolic extract of emblica officinalis on histopathology of kidney and on biochemical parameters in hyperlipidemic albino rats. J Krishna Inst Med Sci Univ 2015;4:41-8.
Malik S, Suchal K, Bhatia J, Khan SI, Vasisth S, Tomar A, et al
. Therapeutic potential and molecular mechanisms of Emblica officinalis
Gaertn in countering nephrotoxicity in rats induced by the chemotherapeutic agent cisplatin. Front Pharmacol 2016;7:350.
Chao CY, Mong MC, Chan KC, Yin MC Antiglycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. MolNutr Food Res 2010;54:388-95
Aggarwal BB, Harikumar KB Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009;41:40-59.
Anonymous. Assessment Report on Curcuma longa
L. Rhizoma. London: European Committee on Herbal medicinal Product, Evaluation of Medicines for Human Use; 2009.
Ponnusamy S, Ravindran R, Zinjarde S, Bhargava S, Kumar AR. Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro. Evid Complement Altern Med 2011:1-10. doi: 10.1155/2011/515647
Seo K-I, Choi M-S, Jung UJ, et al
. Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Mol Nutr Food Res 2008;52:995-1004.
Du ZY, Liu RR, Shao WY, Mao XP, Ma L, Gu LQ, et al
. Alpha-glucosidase inhibition of natural curcuminoids and curcumin analogs. Eur J Med Chem 2006;41:213-8.
Lekshmi PC, Arimboor R, Raghu KG, Menon AN Turmerin, the antioxidant protein from turmeric (Curcuma longa) exhibits antihyperglycaemic effects. Nat Prod Res 2011.
Bedarkar P. Role of Drug Combination w s r to Effect of Nisha, Amalaki and Nisha Amalaki Yoga on Glucose Metabolism and Antidiabetic Effect. PhD thesis. Jamnagar: Gujarat Ayurved University; 2017.
Alodariya N, Pandya DH, Baghel MS Clinical evaluation of Saptavimshatika Guggulu and Haridra Churna in the management of Type-2 diabetes mellitus. J Ayu Herb Med 2017;3:5-10.
Bedarkar P Review of Nisha Amalaki: An Ayurvedic formulation of turmeric and Indian goose berry in diabetes. World J Pharm Med Res 2017;3:101-5.
Yadav RK, Mishra R, Chhipa RP, Audichya KC Clinical trial of an indgenous compound drug nishaamalki in the management of madhumeha vis-à-vis diabetes mellitus. Anc Sci Life 2001;21:18-24.
Trikamji Y editor. Sushruta. Sushruta Samhita (Nibhandasangraha commentary Dalhanacharya and Nyayapanjika commentary of Gayadasa). Sutra Sthana, 45/85. Varanasi: Chaukambha Sanskrit Samsthan, Reprint edition; 2007. p. 203.
Singh RH Charak Samhita of Agnivesha. 1st ed. Varanasi: Chawkhambha Surabharati Prakashana; 2011. Vol. 2. p. 1042.
Anonymous. API (Ayurvedic Pharmacopoea of India). Part I- Volume IV. New Delhi: GOI-Ministry of Health and Family Welfare-Department of Ayush; 2008. p. 143-5.
Trease and Evans. Pharmacognosy. 15th ed. London: Saunders Elsevier; 1996. p. 569-70
Khandelwal KR Practical Pharmacognosy Techniques and Experiments. 19th ed. Pune: Nirali Prakashan; 2008. p. 162-6.
Wallis TE Text Book of Pharmacognosy. 5th ed. New Delhi: CBS Publishers; 2002. p. 210-5, 123-132.
Jawanjal P, Harisha CR, Shukla VJ, Patgiri BJ, Savrikar SS Pharmacognostical and physicochemical evaluation on vata (Ficus benghalensis
Linn.) Jata (aerial roots). Med J Dr. DY Patil Vidyapeeth 2022;15:86.
Jawanjal P, Bedarkar P, Patgiri B, Shukla VJ Phytochemical and high-performance thin-layer chromatography analysis of Ashawattha
Linn.) Kaanda Twaka (outer portion of stem bark) churna (powder). BLDE Univ J Health Sci 2021;6:43. [Full text]
Galib R, Gulati P, Yadav P, Prajapati PK Physicochemical profile and shelf life estimation of Nishamalaki churna
. J Drug Res Ayurved Sci 2018;3:133-40.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]